Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances
Palantir Bulls Face a Reality Check Before EarningsInovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independ
Palantir Bulls Face a Reality Check Before EarningsInovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independ